Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-3750 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

This is a medication for RX only, called Spironolactone. It comes in a box of 100 tablets, each tablet containing 50mg of the drug. The NDC number is 70518-3750-00, the LOT number is not available. This medication was manufactured by Sun Pharma and the source NDC is 53489-0328-01. The medication should be stored at a temperature range of 20-25°C (88-77°F) with short-term excursions allowed between 15-30°C (59-86°F). The directions for use can be found in the package insert. The medicine has been repackaged by RemedyRepack Inc., Indiana, PA 15701. It is important to keep this medicine away from children.*

MM2 - Spironolactone 50mg 70518 3750 01

MM2 - Spironolactone 50mg 70518 3750 01

Spironolactone is a prescription medication that comes in the form of a 50 mg tablet. This tablet should be kept out of reach of children and stored at a temperature of 20-25°C (88-77°F). The medication was manufactured by Sun Pharma in Cranbury, NJ 08512 and has an NDC number of 70518-3750-01. The source NDC for this medication is 53489-0328-01. There is one tablet in each package and the medication should be used as directed in the package insert. The lot number and expiration date are not available. This medication was repackaged by RemedyRepack Inc., Indiana, PA 15701.*

structure - Spironolactone 01

structure - Spironolactone 01

figure 1 - Spironolactone 02

figure 1 - Spironolactone 02

This appears to be a partial report or result of a medical study involving the administration of Spironolactone and Placebo and a comparison of their effects over a period of 48 months. A log-rank p-value of less than 0.001 was obtained, possibly indicating statistical significance of the results. However, without further context it is not possible to determine what kind of study this was or what the specific findings were.*

figure 2 - Spironolactone 03

figure 2 - Spironolactone 03

This is a chart or graph displaying information related to a medical condition such as diabetes, creatinine levels, potassium levels, beta-blockers, and spironolactone, as well as a comparison between two treatments (spironolactone and placebo). No further information can be provided without additional context for the chart or graph.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.